November 9, 2016
PARAMUS, N.J., Oct. 11, 2016 /PRNewswire/ —  (WGCC), a wholly owned subsidiary of PharmaSphere, Inc., announced today that it has launched the first and only 400 mcg/4 mL and 1000 mcg/10 mL multi-dose vials. Dexmedetomidine HCl Injection is currently sold as a 2 mL vial by multiple manufacturers. Dexmedetomidine is also available in ready to...
Read More
© 2023 WG Critical Care, LLC | A PharmaSphere Company | 120 Rte 17 N, Paramus, NJ 07652